Invivyd (IVVD) Enterprise Value (2020 - 2025)
Invivyd (IVVD) posted Enterprise Value of -$226.7 million for Q4 2025, down 166.8% on a QoQ basis from -$85.0 million in Q3 2025, and down 226.88% year-over-year from $178.7 million in Q4 2024.
Invivyd (IVVD) Enterprise Value (2020 - 2025) Analysis & Trends
Invivyd's Enterprise Value history runs 6 years deep, the most recent figure standing at -$226.7 million for Q4 2025.
- Quarterly Enterprise Value fell 226.88% year-over-year to -$226.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$226.7 million (down 226.88% YoY) and the FY2025 annual result came in at -$226.7 million, down 226.88% from the prior year.
- Enterprise Value was -$226.7 million for Q4 2025 at Invivyd, down from -$85.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$34.9 million in Q2 2025 and bottomed at -$542.2 million in Q4 2021.
- A 5-year average of -$227.9 million and a median of -$181.8 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value tumbled 371.55% — and 2022, when it jumped 83.02%.
- Invivyd's Enterprise Value stood at -$542.2 million in 2021, then soared by 83.02% to -$92.1 million in 2022, then slumped by 117.91% to -$200.6 million in 2023, then surged by 65.44% to -$69.3 million in 2024, then tumbled by 226.88% to -$226.7 million in 2025.
- Business Quant data shows IVVD's Enterprise Value at -$226.7 million in Q4 2025, -$85.0 million in Q3 2025, and -$34.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | -226.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -226.69 Mn |
| Sep 30, 2025 | -84.97 Mn |
| Jun 30, 2025 | -34.91 Mn |
| Mar 31, 2025 | -48.08 Mn |
| Dec 31, 2024 | -69.35 Mn |
| Sep 30, 2024 | -106.87 Mn |
| Jun 30, 2024 | -147.88 Mn |
| Mar 31, 2024 | -189.39 Mn |
| Dec 31, 2023 | -200.64 Mn |
| Sep 30, 2023 | -181.82 Mn |
| Jun 30, 2023 | -121.95 Mn |
| Mar 31, 2023 | -126.47 Mn |
| Dec 31, 2022 | -92.08 Mn |
| Sep 30, 2022 | -278.15 Mn |
| Jun 30, 2022 | -474.89 Mn |
| Mar 31, 2022 | -532.22 Mn |
| Dec 31, 2021 | -542.22 Mn |
| Sep 30, 2021 | -478.27 Mn |
| Jun 30, 2021 | -392.51 Mn |
| Dec 31, 2020 | -114.99 Mn |